ID

31575

Beschreibung

Green Tea or Water in Treating Patients With Prostate Cancer Undergoing Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT00685516

Link

https://clinicaltrials.gov/show/NCT00685516

Stichworte

Versionen (1)
  1. 06.09.18 06.09.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

6. September 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT00685516

Englisch

Eligibility Prostate Cancer NCT00685516

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject consents to participate in the trial.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
subject is 40-75 years of age and has a diagnosis of adenocarcinoma of the prostate.
Beschreibung

Age | Adenocarcinoma of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0007112
scheduled to undergo radical prostatectomy.
Beschreibung

Radical prostatectomy Scheduled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0194810
UMLS CUI [1,2]
C0205539
the subject agrees to stop consumption of tea or tea-containing products throughout the entire intervention period except for the tea provided during study intervention.
Beschreibung

Tea Consumption Discontinuation | Tea Product Consumption Discontinuation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0039400
UMLS CUI [1,2]
C0009830
UMLS CUI [1,3]
C1444662
UMLS CUI [2,1]
C0039400
UMLS CUI [2,2]
C1514468
UMLS CUI [2,3]
C0009830
UMLS CUI [2,4]
C1444662
the subject agrees to stop consumption of dietary or vitamin supplements (e.g., lycopene, vitamin e, selenium, genistein) or herbal supplements (e.g., saw palmetto, pc-spes)
Beschreibung

Dietary Supplements Consumption Discontinuation | Vitamin supplement Consumption Discontinuation | Lycopene | Vitamin E | Selenium | Genistein | Herbal Supplements Consumption Discontinuation | Saw palmetto extract | PC-SPES

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0242295
UMLS CUI [1,2]
C0009830
UMLS CUI [1,3]
C1444662
UMLS CUI [2,1]
C0681579
UMLS CUI [2,2]
C0009830
UMLS CUI [2,3]
C1444662
UMLS CUI [3]
C0065331
UMLS CUI [4]
C0042874
UMLS CUI [5]
C0036581
UMLS CUI [6]
C0061202
UMLS CUI [7,1]
C1504473
UMLS CUI [7,2]
C0009830
UMLS CUI [7,3]
C1444662
UMLS CUI [8]
C0771607
UMLS CUI [9]
C0756934
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of hepatitis or liver dysfunction
Beschreibung

Hepatitis | Liver Dysfunction

Datentyp

boolean

Alias
UMLS CUI [1]
C0019158
UMLS CUI [2]
C0086565
ongoing alcohol abuse
Beschreibung

Alcohol abuse

Datentyp

boolean

Alias
UMLS CUI [1]
C0085762
significant medical or psychiatric conditions that would make the patient a poor protocol candidate
Beschreibung

Medical condition Study Subject Participation Status Poor | Mental condition Study Subject Participation Status Poor

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C2700379
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C2700379
prior sensitivity or allergic reaction to tea, tea products, or tea supplements
Beschreibung

Hypersensitivity Tea | Hypersensitivity Tea product | Hypersensitivity Tea Supplements | Allergic Reaction Tea | Allergic Reaction Tea product | Allergic Reaction Tea Supplements

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0039400
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0039400
UMLS CUI [2,3]
C1514468
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0039400
UMLS CUI [3,3]
C0242295
UMLS CUI [4,1]
C1527304
UMLS CUI [4,2]
C0039400
UMLS CUI [5,1]
C1527304
UMLS CUI [5,2]
C0039400
UMLS CUI [5,3]
C1514468
UMLS CUI [6,1]
C1527304
UMLS CUI [6,2]
C0039400
UMLS CUI [6,3]
C0242295
allergy or sensitivity to multiple food items or nutritional supplements
Beschreibung

ALLERGY TO MULTIPLE FOOD | Hypersensitivity Dietary Supplements

Datentyp

boolean

Alias
UMLS CUI [1]
C0744084
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0242295
concurrent luteinizing hormone-releasing hormone agonists, androgen receptor blocking agents, or finasteride
Beschreibung

Luteinizing Hormone-releasing Hormone Agonist | Androgen Receptor Antagonists | Finasteride

Datentyp

boolean

Alias
UMLS CUI [1]
C1518041
UMLS CUI [2]
C2936804
UMLS CUI [3]
C0060389
prior bilateral orchiectomy
Beschreibung

Bilateral orchiectomy

Datentyp

boolean

Alias
UMLS CUI [1]
C0007347
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Prostate Cancer NCT00685516

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
subject consents to participate in the trial.
boolean
C0021430 (UMLS CUI [1])
Age | Adenocarcinoma of prostate
Item
subject is 40-75 years of age and has a diagnosis of adenocarcinoma of the prostate.
boolean
C0001779 (UMLS CUI [1])
C0007112 (UMLS CUI [2])
Radical prostatectomy Scheduled
Item
scheduled to undergo radical prostatectomy.
boolean
C0194810 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
Tea Consumption Discontinuation | Tea Product Consumption Discontinuation
Item
the subject agrees to stop consumption of tea or tea-containing products throughout the entire intervention period except for the tea provided during study intervention.
boolean
C0039400 (UMLS CUI [1,1])
C0009830 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0039400 (UMLS CUI [2,1])
C1514468 (UMLS CUI [2,2])
C0009830 (UMLS CUI [2,3])
C1444662 (UMLS CUI [2,4])
Dietary Supplements Consumption Discontinuation | Vitamin supplement Consumption Discontinuation | Lycopene | Vitamin E | Selenium | Genistein | Herbal Supplements Consumption Discontinuation | Saw palmetto extract | PC-SPES
Item
the subject agrees to stop consumption of dietary or vitamin supplements (e.g., lycopene, vitamin e, selenium, genistein) or herbal supplements (e.g., saw palmetto, pc-spes)
boolean
C0242295 (UMLS CUI [1,1])
C0009830 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0681579 (UMLS CUI [2,1])
C0009830 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C0065331 (UMLS CUI [3])
C0042874 (UMLS CUI [4])
C0036581 (UMLS CUI [5])
C0061202 (UMLS CUI [6])
C1504473 (UMLS CUI [7,1])
C0009830 (UMLS CUI [7,2])
C1444662 (UMLS CUI [7,3])
C0771607 (UMLS CUI [8])
C0756934 (UMLS CUI [9])
Item Group
C0680251 (UMLS CUI)
Hepatitis | Liver Dysfunction
Item
history of hepatitis or liver dysfunction
boolean
C0019158 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
Alcohol abuse
Item
ongoing alcohol abuse
boolean
C0085762 (UMLS CUI [1])
Medical condition Study Subject Participation Status Poor | Mental condition Study Subject Participation Status Poor
Item
significant medical or psychiatric conditions that would make the patient a poor protocol candidate
boolean
C3843040 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C2700379 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C2700379 (UMLS CUI [2,3])
Hypersensitivity Tea | Hypersensitivity Tea product | Hypersensitivity Tea Supplements | Allergic Reaction Tea | Allergic Reaction Tea product | Allergic Reaction Tea Supplements
Item
prior sensitivity or allergic reaction to tea, tea products, or tea supplements
boolean
C0020517 (UMLS CUI [1,1])
C0039400 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0039400 (UMLS CUI [2,2])
C1514468 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0039400 (UMLS CUI [3,2])
C0242295 (UMLS CUI [3,3])
C1527304 (UMLS CUI [4,1])
C0039400 (UMLS CUI [4,2])
C1527304 (UMLS CUI [5,1])
C0039400 (UMLS CUI [5,2])
C1514468 (UMLS CUI [5,3])
C1527304 (UMLS CUI [6,1])
C0039400 (UMLS CUI [6,2])
C0242295 (UMLS CUI [6,3])
ALLERGY TO MULTIPLE FOOD | Hypersensitivity Dietary Supplements
Item
allergy or sensitivity to multiple food items or nutritional supplements
boolean
C0744084 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0242295 (UMLS CUI [2,2])
Luteinizing Hormone-releasing Hormone Agonist | Androgen Receptor Antagonists | Finasteride
Item
concurrent luteinizing hormone-releasing hormone agonists, androgen receptor blocking agents, or finasteride
boolean
C1518041 (UMLS CUI [1])
C2936804 (UMLS CUI [2])
C0060389 (UMLS CUI [3])
Bilateral orchiectomy
Item
prior bilateral orchiectomy
boolean
C0007347 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video